| Cat. No. |
Product Name |
Information |
| PC-72745 |
CHD1Li 6.11
CHD1L inhibitor
|
CHD1Li 6.11 is a first in class, orally bioavailable oncogenic CHD1L inhibitor with 3.3 uM (CHD1L-cat enzyme activity). |
| PC-72727 |
T417
PBX1 inhibitor
|
T417 (PBX1 inhibitor T417, TCRS-417) is a novel small molecule compound capable of docking to the interface between PBX1 and its cognate DNA target sequence, potently interferes with the PBX1-DNA interaction with IC50 of 6.58 uM. |
| PC-72720 |
FGF23 inhibitor 13a
FGF23 inhibitor
|
FGF23 inhibitor 13a (FGF23-IN-13a) is a ZINC13407541 analogue with enhanced drug-like properties, inhibits FGF23 with IC50 of 0.14 uM. |
| PC-72719 |
ZINC13407541
FGF23 inhibitor
|
ZINC13407541 is a small molecule antagonist for FGF23, inhibits FGF-23 signaling with IC50 of 0.45 uM. |
| PC-72714 |
AAA-10
BSH inhibitor
|
AAA-10 (AAA10) is a second-generation gut-restricted pan-bile salt hydrolase (BSH) enzyme inhibitor. |
| PC-72713 |
GAS41 YEATS inhibitor 19
GAS41 YEATS domain inhibitor
|
GAS41 YEATS inhibitor 19 (GAS41 YEATS-IN-19) is potent, selective, cell-permeable dimeric inhibitor of GAS41 YEATS domain with IC50 of 18 nM (AlphaScreen competition assay). |
| PC-72703 |
CASK chemical probe 18
CASK inhibitor
|
CASK chemical probe 18 is a highly potent and selective CASK inhibitor with IC50 of 22 nM. |
| PC-72687 |
Ethanimidothioic acid
Scramblase inhibitor
|
Ethanimidothioic acid (R5421) is an inhibitor of platelet scramblase activity. |
| PC-72664 |
DS96432529
Bone anabolic agent
|
DS96432529 (DS 96432529) is a potent and orally active bone anabolic agent with EC200 value of 0.024 ug/mL. |
| PC-72661 |
Vanin-1 inhibitor
Vanin-1 inhibitor
|
Vanin-1 inhibitor is a potent, selective, oral Vanin-1 inhibitor with IC50 of 3.4 and 1.5 nM for human and mouse Vanin-1, respectively. |
| PC-72660 |
PFI-653
Vanin-1 inhibitor
|
PFI-653 (Vanin-1-IN-1) is a highly potent vanin-1 inhibitor with IC50 of 6.8 nM (human Vanin-1). |
| PC-72652 |
JNJ-40929837
LTA4H inhibitor
|
JNJ-40929837 (JNJ40929837) is a potent, highly selective, oral leukotriene A4 hydrolase (LTA4H) inhibitor with IC50 of 1.9 nM, demonstrates high potency (IC50=48 nM) in human whole blood ionophore-stimulated LTB4 release assay. |
